BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34850763)

  • 1. Dosimetry study of nasopharyngeal carcinoma based on Halcyon accelerator fixed-field intensity-modulated radiation therapy.
    Li K; Li C; Zhu T; Chen J; Cao W; Yin Y; Ma C
    J Cancer Res Ther; 2021 Nov; 17(5):1165-1171. PubMed ID: 34850763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is 9-field IMRT superior to 7-field IMRT in the treatment of nasopharyngeal carcinoma?
    Ibrahim MS; Attalla EM; El Naggar M; Elshemey WM
    Indian J Cancer; 2020; 57(4):388-392. PubMed ID: 33078744
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
    Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous integrated boost therapy of carcinoma of the hypopharynx/larynx with and without flattening filter - a treatment planning and dosimetry study.
    Dobler B; Obermeier T; Hautmann MG; Khemissi A; Koelbl O
    Radiat Oncol; 2017 Jul; 12(1):114. PubMed ID: 28679448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A plan comparison study between rapid arc and conventional intensity-modulated radiation treatment plans in nasopharyngeal carcinoma patients.
    Patidar Y; Kumar HS; Sharma N; Mayilvaganan A
    J Cancer Res Ther; 2023; 19(3):543-547. PubMed ID: 37470572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early clinical experience with varian halcyon V2 linear accelerator: Dual-isocenter IMRT planning and delivery with portal dosimetry for gynecological cancer treatments.
    Kim H; Huq MS; Lalonde R; Houser CJ; Beriwal S; Heron DE
    J Appl Clin Med Phys; 2019 Nov; 20(11):111-120. PubMed ID: 31660682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric comparison of intensity modulated radiotherapy and intensity modulated proton therapy in the treatment of recurrent nasopharyngeal carcinoma.
    Hung HM; Chan OCM; Mak CH; Hung WM; Ng WT; Lee MCH
    Med Dosim; 2022 Spring; 47(1):14-19. PubMed ID: 34470708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of dose-volume histogram prediction for organ-at risk and planning target volume based on machine learning.
    Jiao SX; Wang ML; Chen LX; Liu XW
    Sci Rep; 2021 Feb; 11(1):3117. PubMed ID: 33542427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment planning comparison of volumetric modulated arc therapy with the trilogy and the Halcyon for bilateral breast cancer.
    Sun T; Lin X; Zhang G; Qiu Q; Li C; Yin Y
    Radiat Oncol; 2021 Feb; 16(1):35. PubMed ID: 33602267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the assignment method of intensity modulated radiotherapy plan for nasopharyngeal carcinoma based on MR images].
    Yao XS; Gong GZ; Ren JX; Zuo GP; Yin Y
    Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):850-855. PubMed ID: 34407590
    [No Abstract]   [Full Text] [Related]  

  • 12. Dosimetric study of the plan quality and dose to organs at risk on tangential breast treatments using the Halcyon linac.
    Flores-Martinez E; Kim GY; Yashar CM; Cerviño LI
    J Appl Clin Med Phys; 2019 Jul; 20(7):58-67. PubMed ID: 31183967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric comparison between VMAT plans using the fast-rotating O-ring linac with dual-layer stacked MLC and helical tomotherapy for nasopharyngeal carcinoma.
    Ju SG; Ahn YC; Kim YB; Kim JM; Kwon DY; Park BS; Yang K
    Radiat Oncol; 2022 Sep; 17(1):155. PubMed ID: 36096874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volumetric intensity-modulated arc therapy vs conventional intensity-modulated radiation therapy in nasopharyngeal carcinoma: a dosimetric study.
    White P; Chan KC; Cheng KW; Chan KY; Chau MC
    J Radiat Res; 2013 May; 54(3):532-45. PubMed ID: 23188186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A knowledge-based intensity-modulated radiation therapy treatment planning technique for locally advanced nasopharyngeal carcinoma radiotherapy.
    Bai P; Weng X; Quan K; Chen J; Dai Y; Xu Y; Lin F; Zhong J; Wu T; Chen C
    Radiat Oncol; 2020 Aug; 15(1):188. PubMed ID: 32746873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced nasopharyngeal carcinoma radiotherapy with volumetric modulated arcs and the potential role of flattening filter-free beams.
    Zhuang M; Zhang T; Chen Z; Lin Z; Li D; Peng X; Qiu Q; Wu R
    Radiat Oncol; 2013 May; 8():120. PubMed ID: 23672519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of sliding window and field-in-field techniques for tangential whole breast irradiation using the Halcyon and Synergy Agility systems.
    Richter A; Wegener S; Breuer K; Razinskas G; Weick S; Exner F; Bratengeier K; Flentje M; Sauer O; Polat B
    Radiat Oncol; 2021 Nov; 16(1):213. PubMed ID: 34742291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasopharyngeal carcinoma radiotherapy with hybrid technique.
    Akbas U; Koksal C; Kesen ND; Ozkaya K; Bilge H; Altun M
    Med Dosim; 2019 Autumn; 44(3):251-257. PubMed ID: 30366620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of constant dose rate VMAT in the treatment of nasopharyngeal cancer patients.
    Yu W; Shang H; Xie C; Han C; Yi J; Zhou Y; Jin X
    Radiat Oncol; 2014 Nov; 9():235. PubMed ID: 25366034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential for reduced radiation-induced toxicity using intensity-modulated arc therapy for whole-brain radiotherapy with hippocampal sparing.
    Pokhrel D; Sood S; Lominska C; Kumar P; Badkul R; Jiang H; Wang F
    J Appl Clin Med Phys; 2015 Sep; 16(5):131–141. PubMed ID: 26699321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.